Glucose B.Braun

Glucose B.Braun is a sterile aqueous solution of glucose monohydrate supplied for intravenous use. It is a parenteral nutrition solution that provides a source of carbohydrate for energy metabolism. The product is marketed in the European Union and is available by prescription only. It is administered as a solution for injection under aseptic conditions. Each vial contains a sterile, isotonic formulation designed for compatibility with standard infusion sets.

Glucose B.Braun is indicated for several clinical situations where intravenous carbohydrate delivery is required.

- Parenteral nutrition in patients unable to receive enteral feeding. - Treatment of hypoglycemia when oral glucose is not feasible. - Fluid and electrolyte replacement as part of balanced IV therapy. - Intra‑operative glucose support during surgery. - Management of metabolic demands in critically ill patients.

Intravenous administration of glucose monohydrate may be associated with both common and serious adverse reactions.

Common: - Transient hyperglycemia. - Local irritation or phlebitis at the infusion site. - Electrolyte shifts, particularly mild hypokalemia. - Fluid overload in patients receiving large volumes.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic or anaphylactic reaction to the solution. - Significant volume overload causing pulmonary edema. - Marked electrolyte disturbances such as severe hypokalemia or hypernatremia.

Clinicians should observe several precautions when prescribing or administering Glucose B.Braun to ensure patient safety.

- Verify blood glucose levels before and during infusion. - Assess fluid balance and avoid excessive volume in patients with cardiac or renal impairment. - Monitor serum electrolytes, especially potassium and sodium, during prolonged therapy. - Use caution in patients with known hypersensitivity to glucose solutions. - Consider pregnancy status; safety data are limited. - Ensure compatibility with other IV medications before mixing.

Glucose B.Braun can interact with other agents administered intravenously; some combinations should be avoided while others require careful monitoring.

Avoid: - Co‑administration with other hypertonic dextrose solutions that may cause severe hyperglycemia. - Simultaneous infusion of insulin in excess of the glucose load without appropriate monitoring.

Use with caution: - Diuretics that may exacerbate electrolyte shifts. - Corticosteroids, which can increase glucose levels. - Beta‑adrenergic agonists that may raise blood glucose. - Other IV fluids containing electrolytes that could alter serum balance. - Medications affecting potassium, such as potassium‑sparing diuretics.